Work

Phase II study of durvalumab following neoadjuvant chemoRT in stage II-IV rectal cancer: NSABP FR-2.

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

Authors: Thomas J. George, Greg Yothers, James J. Lee, Melvin Deutsch, Samuel A. Jacobs, Carmen Joseph Allegra, Norman Wolmark

Institutions: NRG Oncology, UF Health Cancer Center, University of Pittsburgh, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, University of Florida, Allegheny Health Network

Language: English

Topic: Colorectal Cancer Surgical Treatments

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2947986527

Cites:

Cited by: 1

Related to: 10